Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics of Urinary Alkalinization Therapy in Patients With Nephrolithiasis
NCT06819111Phase 1Not yet recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of potassium citrate + magnesium citrate in nephrolithiasis, sponsored by UT Southwestern Medical Center. Primary endpoint: Urinary pH at 6 weeks. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
potassium citrate + magnesium citrate
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT06819111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819111.